ARCHIVES

ACS Division Help Fund Some CIS Offices

This article is from The Cancer Letter archive.

Vol. 11 No. 35 | September 13, 1985

Download PDF Visit The Full Archive

Related Articles

Genetic Testing: No Easy Answers To Public Questions

May 15, 1998

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Organ Systems Working Group Chairs Ask for Set-Aside Funds

December 6, 1985

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

NCI’s Supercomputer Undergoing Testing

April 11, 1986

Conference Bill Includes Funding For DOD For Breast, Prostate, Ovarian Cancer

October 4, 1996